期刊文献+

TGF-β1、HIF-1α、VEGF在胃癌组织及癌旁组织中的表达及临床意义 被引量:8

Expression and Clinical Significance of TGF-β1, HIF-1α, VEGF in Gastric Cancer Tissues and Corresponding Adjacent Noncancerous Tissues
原文传递
导出
摘要 目的:研究TGF-β1(转化生长因子-β1)、HIF-1α(低氧诱导因子-1α)、VEGF(血管内皮生长因子)在胃癌组织及癌旁组织中的表达及临床意义。方法:选取于我院就诊的160例胃癌手术患者切除的组织,采用免疫组化技术检测手术切除的胃癌组织中的TGF-β1、HIF-1α及VEGF的表达,分析其与患者临床病理参数的关系。结果:免疫组化结果显示:TGF-β1、HIF-1α及VEGF在胃癌组织中的表达均高于癌旁组织,差异均有统计学意义(P<0.05);TGF-β1、HIF-1α及VEGF的表达均与肿瘤分期、淋巴结转移及浸润深度有关(P<0.05);VEGF的表达分别与TGF-β1、HIF-1α的表达呈相关关系(P<0.05)。结论:TGF-β1、HIF-1α及VEGF在胃癌组织中的表达与胃癌的病理学特征有关,检测TGF-β1、HIF-1α及VEGF的表达将有助于临床诊治胃癌患者。 Objective: To study the expression of TGF-β1(Transforming growth factor-β1), HIF-1α(Hypoxia-inducible factor-1α), VEGF(Vascular endothelial growth factor) and their clinical significance in gastric cancer tissues and corresponding adjacent noncancerous tissues. Method: 160 cases of gastric carcinoma tissues were chosen to detect the expression of TGF-β1, HIF-1α and VEGF in gastric carcinoma tissues which had been removed by the immunohistochemistry technology. The relationship between the expression and the clinical pathological parameters of patients were analyzed. Results: Immunohistochemistry showed: The expression of TGF-β1,HIF-1α, VEGF in gastric carcinoma tissues was higher than in corresponding adjacent noncancerous tissues, the differences were all statistically significant(P〈0.05); the expression of TGF-β1, HIF-1α, VEGF was all related with neoplasm staging, lymphatic metastasis and infiltration depth(P〈0.05). The expression of VEGF were related with the expression of TGF-β1 and HIF-1α(P〈0.05). Conclusion: The expression of TGF-β1, HIF-1α, VEGF in gastric carcinoma tissues were correlated with the pathological features of gastric carcinoma, detecting the expression of TGF-β1, HIF-1α, VEGF will be helpful to clinical diagnosis and treatment of patients with gastric carcinoma.
出处 《现代生物医学进展》 CAS 2014年第18期3524-3527,共4页 Progress in Modern Biomedicine
关键词 胃癌 TGF-Β1 HIF-1Α VEGF Gastric cancer TGF-β1 HIF-1α VEGF
  • 相关文献

参考文献8

  • 1Dali Zhao,Bo Zhai,Changjun He,Gang Tan,Xian Jiang,Shangha Pan,Xuesong Dong,Zheng Wei,Lixin Ma,Haiquan Qiao,Hongchi Jiang,Xueying Sun.Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells[J].Cellular Signalling.2014
  • 2Asta Hautam?ki,Jarno Kivioja,Sanna Seitsonen,Eeva-Riitta Savolainen,M. Johanna Liinamaa,Arto Luoma,Irma J?rvel?,Ilkka Immonen.The IL-8 , VEGF and CFH Polymorphisms and Bevacizumab in Age-Related Macular Degeneration[J].Ophthalmology.2013
  • 3Sung Wook Park,Jin Hyoung Kim,Ko‐Eun Kim,Moon Hee Jeong,Hyunsung Park,Bongju Park,Young‐Ger Suh,Woo Jin Park,Jeong Hun Kim.Beta‐lapachone inhibits pathological retinal neovascularization in oxygen‐induced retinopathy via regulation of HIF ‐1α[J].J Cell Mol Med.2014(5)
  • 4Anette Weyergang,Lawrence H. Cheung,Michael G. Rosenblum,Khalid A. Mohamedali,Qian Peng,Johannes Waltenberger,Kristian Berg.Photochemical internalization augments tumor vascular cytotoxicity and specificity of VEGF 121 /rGel fusion toxin[J].Journal of Controlled Release.2014
  • 5S. Mia,A. Warnecke,X.‐M. Zhang,V. Malmstr?m,R. A. Harris.An optimized Protocol for Human M2 Macrophages using M‐ CSF and IL ‐4/ IL ‐10/ TGF ‐ β Yields a Dominant Immunosuppressive Phenotype[J].Scand J Immunol.2014(5)
  • 6Zita A. Sibenaller,Jessemae L. Welsh,Changbin Du,Jordan R. Witmer,Hannah E. Schrock,Juan Du,Garry R. Buettner,Prabhat C. Goswami,John A. Cieslak,Joseph J. Cullen.Extracellular Superoxide Dismutase (EcSOD) Suppresses Hypoxia-Inducible Factor-1α (HIF-1α) in Pancreatic Cancer[J].Free Radical Biology and Medicine.2014
  • 7Li-Hsun Chang,Shiow-Lin Pan,Chin-Yu Lai,An-Chi Tsai,Che-Ming Teng.Activated PAR-2 Regulates Pancreatic Cancer Progression through ILK/HIF-α–Induced TGF-α Expression and MEK/VEGF-A–Mediated Angiogenesis[J].The American Journal of Pathology.2013(2)
  • 8Ilias Georgalas,Dimitris Papaconstantinou,Kostas Papadopoulos,Dionisis Pagoulatos,Dimitris Karagiannis,Chryssanthi Koutsandrea.Renal Injury Following Intravitreal Anti-VEGF Administration in Diabetic Patients with Proliferative Diabetic Retinopathy and Chronic Kidney Disease - A Possible Side Effect?[J].Current Drug Safety.2014(2)

同被引文献123

引证文献8

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部